uracil has been researched along with Common Bile Duct Neoplasms in 6 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
Common Bile Duct Neoplasms: Tumor or cancer of the COMMON BILE DUCT including the AMPULLA OF VATER and the SPHINCTER OF ODDI.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to clarify the safety and efficacy of combination chemotherapy of uracil-tegafur (UFT) and doxorubicin (UFD regimen), and to identify the prognostic factors in patients with unresectable advanced biliary tract cancer who received systemic chemotherapy." | 9.14 | A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer. ( Boku, N; Funakoshi, A; Furuse, J; Nagase, M; Ohkawa, S; Okusaka, T; Sato, T; Yamaguchi, T; Yamao, K, 2009) |
| "The purpose of this study was to clarify the safety and efficacy of combination chemotherapy of uracil-tegafur (UFT) and doxorubicin (UFD regimen), and to identify the prognostic factors in patients with unresectable advanced biliary tract cancer who received systemic chemotherapy." | 5.14 | A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer. ( Boku, N; Funakoshi, A; Furuse, J; Nagase, M; Ohkawa, S; Okusaka, T; Sato, T; Yamaguchi, T; Yamao, K, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furuse, J | 1 |
| Okusaka, T | 1 |
| Ohkawa, S | 1 |
| Nagase, M | 1 |
| Funakoshi, A | 1 |
| Boku, N | 1 |
| Yamao, K | 1 |
| Yamaguchi, T | 1 |
| Sato, T | 2 |
| Kitami, CE | 1 |
| Kurosaki, I | 1 |
| Koyama, Y | 1 |
| Makino, H | 1 |
| Hatakeyama, K | 1 |
| Ishikawa, T | 1 |
| Ishikawa, N | 2 |
| Oota, H | 1 |
| Yoshida, T | 1 |
| Honma, A | 1 |
| Kamimura, T | 1 |
| Takeda, K | 1 |
| Ozaki, T | 1 |
| Iguchi, C | 1 |
| Nio, Y | 1 |
| Sato, Y | 1 |
| Watanabe, H | 1 |
| Ohishi, T | 1 |
| Abe, M | 1 |
| Yano, S | 1 |
| Sumi, S | 1 |
| Tamura, K | 1 |
| Moreira, LF | 1 |
| Iwagaki, H | 1 |
| Hizuta, A | 1 |
| Sakagami, K | 1 |
| Mimura, H | 1 |
| Orita, K | 1 |
| Shibata, T | 1 |
| Kondo, H | 1 |
| Ootani, I | 1 |
| Suzuki, H | 1 |
| Kawada, S | 1 |
1 trial available for uracil and Common Bile Duct Neoplasms
| Article | Year |
|---|---|
A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Topics: Aged; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Du | 2009 |
5 other studies available for uracil and Common Bile Duct Neoplasms
| Article | Year |
|---|---|
Long-term survival after hepatectomy for hepatic recurrence of carcinoma of the papilla of Vater.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Aged; Ampulla of Vater; Antineoplastic Combined | 2005 |
[A case of common bile duct cancer responding to MMC leucovorin, 5-FU, and UFT combination chemotherapy and radiation].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Common Bile Duct Ne | 1996 |
[A case of recurrent ampullary carcinoma of the papilla of Vater, in which a complete response was induced by combination therapy using radiotherapy and oral chemotherapy employing UFT and cyclophosphamide].
Topics: Administration, Oral; Adult; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Combi | 1999 |
Can cytokines prolong survival in ampullary neuroendocrine carcinomas?
Topics: Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Combined Modality Thera | 1992 |
[Two cases of obstructive jaundice due to extrahepatic carcinoma of the bile duct with marked response to daily oral administration of etoposide].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chole | 1990 |